Academisch Ziekenhuis Leiden competitive analysis

Explore Academisch Ziekenhuis Leiden's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 16, 2022Treating Pathological Conditions By Direct And Indirect Targeting Of Sirpa - Cd47 Interaction1
Apr 6, 2022Means And Methods For Counteracting Muscle Disorders2
Oct 14, 2020Newborn Support Device And Resuscitation Device1
Feb 28, 2018Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1
Apr 27, 2016Induction Of Exon Skipping In Eukaryotic Cells1
Mar 2, 2016Induction Of Exon Skipping In Eukaryotic Cells2
Jan 6, 2016Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1
Dec 30, 2015Induction Of Exon Skipping In Eukaryotic Cells2
Dec 30, 2015Induction Of Exon Skipping In Eukaryotic Cells1
Dec 30, 2015Induction Of Exon Skipping In Eukaryotic Cells1

Latest PTAB cases involving Academisch Ziekenhuis Leiden

Discover the latest PTAB cases involving Academisch Ziekenhuis Leiden, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Academisch Ziekenhuis Leiden with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACADEMISCH ZIEKENHUIS LEIDEN HODN LUMC - 2 - -
LUNT1 - - -
STRAWMAN468 - - -